UK pharma major AstraZeneca on Friday announced an agreement with US President Donald Trump’s administration to lower the ...

South Korea-based Celltrion on Friday announced that the US Food and Drug Administration (FDA) has approved Eydenzelt ...

German pharma major Bayer’s gene therapy subsidiary AskBio today announced initial safety data from the first cohort of ...

US biotech major Biogen and RNA medicine specialist Stoke Therapeutics have presented longer-term follow-up analyses from the ...

Switzerland-based Ypsomed will establish its first manufacturing facility in the USA, selecting Holly Springs in Wake County, North Carolina, as the location.

An Expert View from Agnese Cattaneo, Chief Medical Officer at Angelini Pharma.

US pharma major Bristol Myers Squibb has entered into a definitive agreement to acquire Orbital Therapeutics, a privately ...

Swedish oncology specialist Xspray Pharma has received a complete response letter (CRL) from the US Food and Drug ...

Swiss biopharma firm Idorsia yesterday announced that it has successfully raised 65.6 million francs ($83 million) through ...

Spanish plasma-based medicines producer Grifols announced that Yimmugo, an innovative intravenous immunoglobulin (IVIg) ...

UK pharma major AstraZeneca announced that it will now invest $4.5 billion in its new manufacturing facility in Virginia, a ...

US venture firm Ascenta Capital has closed its inaugural fund at $325 million, marking a significant milestone two years ...